Pierre Fabre Pharma GmbH
🇩🇪Germany
BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
Recruiting
- Conditions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 500
- Registration Number
- NCT04673955
- Locations
- 🇩🇪
Prctice, Naunhof, Sachsen, Germany
🇩🇪Private Practice, Würzburg, Germany
🇩🇪Clinic, Berlin, Germany
Real-life Pan-HER-blockade With Neratinib
Active, not recruiting
- Conditions
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 304
- Registration Number
- NCT04388384
- Locations
- 🇩🇪
Community Health Center, Neuss, North Rhine-Westphalia, Germany
🇩🇪Medical Praxis, Freital, Sachsen, Germany
🇨ðŸ‡Practice, Biel, Bern, Switzerland
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Recruiting
- Conditions
- First Posted Date
- 2019-08-05
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 750
- Registration Number
- NCT04045691
- Locations
- 🇩🇪
45, Ahaus, Germany
🇦🇹53, Wien, Austria
🇩🇪49, Dresden, Germany
Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria
Completed
- Conditions
- First Posted Date
- 2015-12-02
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 108
- Registration Number
- NCT02619929
JAVLOR® Online Non-Interventional Trial
Completed
- Conditions
- First Posted Date
- 2010-04-14
- Last Posted Date
- 2015-05-13
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 200
- Registration Number
- NCT01103544
- Locations
- 🇩🇪
Pierre Fabre Pharma GmbH, Freiburg, Germany
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)
Completed
- Conditions
- First Posted Date
- 2009-04-30
- Last Posted Date
- 2012-07-02
- Lead Sponsor
- Pierre Fabre Pharma GmbH
- Target Recruit Count
- 62
- Registration Number
- NCT00890903
- Locations
- 🇩🇪
Pierre Fabre Pharma GmbH, Freiburg, Germany
© Copyright 2024. All Rights Reserved by MedPath